(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RISBANDIS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RISBANDIS

ST13

US500000079286053

Class

5

Filing

79286053

Registration

6177331

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

01/30/2021

Trademark type

Word

Nice classes

5

Filing date

04/14/2020

Registration date

10/20/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/20/2020

Last transaction

01/30/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

09

Owner location

ES

Examiner

BRACEY, KAREN

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

LABORATORIOS FARMACEUTICOS ROVI, S.A.

Representatives

BALDER IP LAW, S.L.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical productstranquilizersprescription synthetic narcoticsantidepressantsanxiolyticsantipsychotics; chemical products for medical usebeing pharmaceuticals for treating schizophrenia; chemical pharmaceuticals for the treatment of diseases of the central nervous system; disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseases; preparations for the treatment of diseases of the central nervous system; preparations for the treatment of schizophrenia

Publications

History of USPTO decisions and trademark events.

17 publications found

GPNX

NOTIFICATION PROCESSED BY IB

01/30/2021

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

12/08/2020

XXCR

GENERIC MADRID TRANSACTION CREATED

12/08/2020

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

11/19/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

10/20/2020

PUBO

PUBLISHED FOR OPPOSITION

08/04/2020

GPNX

NOTIFICATION PROCESSED BY IB

07/31/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/15/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/15/2020

NPUB

NOTICE OF PUBLICATION

07/15/2020

ALIE

ASSIGNED TO LIE

07/02/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/01/2020

DOCK

ASSIGNED TO EXAMINER

06/30/2020

MAFR

APPLICATION FILING RECEIPT MAILED

06/02/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/29/2020

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

05/29/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/21/2020

Continuous trademark protection

Get notified about every new filing that threatens RISBANDIS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.